Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Fleming

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Infectious Diseases|July 24, 2004
Some design issues in trials of microbicides for the prevention of HIV infectionThomas R Fleming, Barbra A Richardson
The New England Journal of Medicine|June 21, 2023
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19Dan-Yu Lin, Thomas R Fleming
Statistics in Medicine|May 4, 2004
The independent statistician for data monitoring committeesDavid L DeMets, Thomas R Fleming
Statistics in Medicine|June 20, 2012
Biomarkers and surrogate endpoints in clinical trialsThomas R Fleming, John H Powers
Journal of Clinical Epidemiology|July 14, 2020
Achieving effective informed oversight by DMCs in COVID clinical trialsDavid L DeMets, Thomas R Fleming
JAMA|May 29, 2020
Conducting Clinical Research During the COVID-19 Pandemic: Protecting Scientific IntegrityThomas R Fleming, Dominic Labriola, Janet Wittes
Statistical Communications in Infectious Diseases|March 29, 2021
Designing & Conducting Trials To Reliably Evaluate HIV Prevention InterventionsThomas R Fleming, Victor DeGruttola, Deborah Donnell
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2008
Executive summary: workshop on issues in the design and conduct of clinical trials of antibacterial drugs in the treatment of community-acquired pneumoniaBrad Spellberg, Thomas R Fleming, David N Gilbert
American Journal of Respiratory and Critical Care Medicine|May 31, 2024
Reply to Stowasser <i>et al.</i>: Assessing How Patients Feel, Function, and Survive in Idiopathic Pulmonary Fibrosis: The Best Is the Enemy of the GoodGanesh Raghu, Thomas R Fleming, Fernando J Martinez
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2011
Challenges in the design of HIV prevention trials in the United StatesDeborah Donnell, James P Hughes, Thomas R Fleming
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Infectious Diseases|July 24, 2004
Some design issues in trials of microbicides for the prevention of HIV infectionThomas R Fleming, Barbra A Richardson
The New England Journal of Medicine|June 21, 2023
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19Dan-Yu Lin, Thomas R Fleming
Statistics in Medicine|May 4, 2004
The independent statistician for data monitoring committeesDavid L DeMets, Thomas R Fleming
Statistics in Medicine|June 20, 2012
Biomarkers and surrogate endpoints in clinical trialsThomas R Fleming, John H Powers
Journal of Clinical Epidemiology|July 14, 2020
Achieving effective informed oversight by DMCs in COVID clinical trialsDavid L DeMets, Thomas R Fleming
JAMA|May 29, 2020
Conducting Clinical Research During the COVID-19 Pandemic: Protecting Scientific IntegrityThomas R Fleming, Dominic Labriola, Janet Wittes
Statistical Communications in Infectious Diseases|March 29, 2021
Designing & Conducting Trials To Reliably Evaluate HIV Prevention InterventionsThomas R Fleming, Victor DeGruttola, Deborah Donnell
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2008
Executive summary: workshop on issues in the design and conduct of clinical trials of antibacterial drugs in the treatment of community-acquired pneumoniaBrad Spellberg, Thomas R Fleming, David N Gilbert
American Journal of Respiratory and Critical Care Medicine|May 31, 2024
Reply to Stowasser <i>et al.</i>: Assessing How Patients Feel, Function, and Survive in Idiopathic Pulmonary Fibrosis: The Best Is the Enemy of the GoodGanesh Raghu, Thomas R Fleming, Fernando J Martinez
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2011
Challenges in the design of HIV prevention trials in the United StatesDeborah Donnell, James P Hughes, Thomas R Fleming
Pageof 11